{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:24Z","timestamp":1758970584741},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Compromised brain cholesterol turnover and altered regulation of brain cholesterol metabolism have been allied with some neurodegenerative diseases, including Huntington\u2019s disease (HD). Following our previous studies in HD, in this study we aim to investigate in vitro in a neuroblastoma cellular model of HD, the effect of CYP46A1 overexpression, an essential enzyme in cholesterol metabolism, on huntingtin aggregation and levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that CYP46A1 reduces the quantity and size of mutant huntingtin aggregates in cells, as well as the levels of mutant huntingtin protein. Additionally, our results suggest that the observed beneficial effects of CYP46A1 in HD cells are linked to the activation of autophagy. Taken together, our results further demonstrate that CYP46A1 is a pertinent target to counteract HD progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-020-05053-x","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:02:12Z","timestamp":1586548932000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Cl\u00e9vio","family":"N\u00f3brega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Koppenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel L.","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Carmo-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Marcelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Betuing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyne","family":"Caboche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"5053_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10:204\u201316.","journal-title":"Nat Rev Neurol"},{"key":"5053_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ. Huntington\u2019s disease: a clinical review. Eur J Neurol. 2018;25:24\u201334.","journal-title":"Eur J Neurol"},{"key":"5053_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/WCO.0000000000000116","volume":"27","author":"SD Kim","year":"2014","unstructured":"Kim SD, Fung VS. An update on Huntington\u2019s disease: from the gene to the clinic. Curr Opin Neurol. 2014;27:477\u201383.","journal-title":"Curr Opin Neurol"},{"key":"5053_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/glia.23050","volume":"65","author":"AH Jansen","year":"2017","unstructured":"Jansen AH, van Hal M, Op den Kelder IC, Meier RT, de Ruiter AA, Schut MH, Smith DL, Grit C, Brouwer N, Kamphuis W, Boddeke HW, den Dunnen WF, van Roon WM, Bates GP, Hol EM, Reits EA. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific. Glia. 2017;65:50\u201361.","journal-title":"Glia"},{"key":"5053_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000;23:217\u201347.","journal-title":"Annu Rev Neurosci"},{"key":"5053_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol. 1985;44:559\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 7","key":"5053_CR7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","volume":"121","author":"AD Lawrence","year":"1998","unstructured":"Lawrence AD, Hodges JR, Rosser AE, Kershaw A, Ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ. Evidence for specific cognitive deficits in preclinical Huntington\u2019s disease. Brain J Neurol. 1998;121(Pt 7):1329\u201341.","journal-title":"Brain J Neurol"},{"key":"5053_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1212\/WNL.62.3.523-a","volume":"62","author":"J Kassubek","year":"2004","unstructured":"Kassubek J, Gaus W, Landwehrmeyer GB. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology. 2004;62:523\u20134 (author reply 524).","journal-title":"Neurology"},{"key":"5053_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA. Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40.","journal-title":"Orphanet J Rare Dis"},{"key":"5053_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron. 2019;101:801\u201319.","journal-title":"Neuron"},{"key":"5053_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1242\/dmm.010124","volume":"5","author":"JE Vance","year":"2012","unstructured":"Vance JE. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Models Mech. 2012;5:746\u201355.","journal-title":"Dis Models Mech"},{"key":"5053_CR12","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuropharm.2008.02.019","volume":"55","author":"Z Korade","year":"2008","unstructured":"Korade Z, Kenworthy AK. Lipid rafts, cholesterol, and the brain. Neuropharmacology. 2008;55:1265\u201373.","journal-title":"Neuropharmacology"},{"key":"5053_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.15252\/embr.201439225","volume":"15","author":"MG Martin","year":"2014","unstructured":"Martin MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014;15:1036\u201352.","journal-title":"EMBO Rep"},{"key":"5053_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1742-4658.2008.06808.x","volume":"276","author":"N Camargo","year":"2009","unstructured":"Camargo N, Smit AB, Verheijen MH. SREBPs: SREBP function in glia-neuron interactions. FEBS J. 2009;276:628\u201336.","journal-title":"FEBS J"},{"key":"5053_CR15","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1074\/jbc.R100057200","volume":"277","author":"JM Dietschy","year":"2002","unstructured":"Dietschy JM, Turley SD. Control of cholesterol turnover in the mouse. J Biol Chem. 2002;277:3801\u20134.","journal-title":"J Biol Chem"},{"key":"5053_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bjorkhem","year":"2004","unstructured":"Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004;24:806\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5053_CR17","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bjorkhem","year":"1998","unstructured":"Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39:1594\u2013600.","journal-title":"J Lipid Res"},{"key":"5053_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-2275(20)32337-3","volume":"42","author":"S Meaney","year":"2001","unstructured":"Meaney S, Hassan M, Sakinis A, Lutjohann D, von Bergmann K, Wennmalm A, Diczfalusy U, Bjorkhem I. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. J Lipid Res. 2001;42:70\u20138.","journal-title":"J Lipid Res"},{"key":"5053_CR19","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","volume":"96","author":"EG Lund","year":"1999","unstructured":"Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA. 1999;96:7238\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5053_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1471-4159.2010.07079.x","volume":"116","author":"AO Sodero","year":"2011","unstructured":"Sodero AO, Trovo L, Iannilli F, Van Veldhoven P, Dotti CG, Martin MG. Regulation of tyrosine kinase B activity by the Cyp46\/cholesterol loss pathway in mature hippocampal neurons: relevance for neuronal survival under stress and in aging. J Neurochem. 2011;116:747\u201355.","journal-title":"J Neurochem"},{"key":"5053_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fnmol.2017.00211","volume":"10","author":"S Ayciriex","year":"2017","unstructured":"Ayciriex S, Djelti F, Alves S, Regazzetti A, Gaudin M, Varin J, Langui D, Bieche I, Hudry E, Dargere D, Aubourg P, Auzeil N, Laprevote O, Cartier N. Neuronal cholesterol accumulation induced by Cyp46a1 down-regulation in mouse hippocampus disrupts brain lipid homeostasis. Front Mole Neurosci. 2017;10:211.","journal-title":"Front Mole Neurosci"},{"key":"5053_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awv384","volume":"139","author":"L Boussicault","year":"2016","unstructured":"Boussicault L, Alves S, Lamaziere A, Planques A, Heck N, Moumne L, Despres G, Bolte S, Hu A, Pages C, Galvan L, Piguet F, Aubourg P, Cartier N, Caboche J, Betuing S. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease. Brain J Neurol. 2016;139:953\u201370.","journal-title":"Brain J Neurol"},{"key":"5053_CR23","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/brain\/awv166","volume":"138","author":"F Djelti","year":"2015","unstructured":"Djelti F, Braudeau J, Hudry E, Dhenain M, Varin J, Bieche I, Marquer C, Chali F, Ayciriex S, Auzeil N, Alves S, Langui D, Potier MC, Laprevote O, Vidaud M, Duyckaerts C, Miles R, Aubourg P, Cartier N. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer\u2019s disease. Brain J Neurol. 2015;138:2383\u201398.","journal-title":"Brain J Neurol"},{"key":"5053_CR24","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awz174","volume":"142","author":"R Kacher","year":"2019","unstructured":"Kacher R, Lamaziere A, Heck N, Kappes V, Mounier C, Despres G, Dembitskaya Y, Perrin E, Christaller W, Sasidharan Nair S, Messent V, Cartier N, Vanhoutte P, Venance L, Saudou F, Neri C, Caboche J, Betuing S. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease. Brain J Neurol. 2019;142:2432\u201350.","journal-title":"Brain J Neurol"},{"key":"5053_CR25","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M, Mariotti C, Di Donato S, Corsini A, Bates G, Pruss R, Olson JM, Sipione S, Tartari M, Cattaneo E. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci. 2005;25:9932\u20139.","journal-title":"J Neurosci"},{"key":"5053_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","volume":"28","author":"M Valenza","year":"2007","unstructured":"Valenza M, Leoni V, Tarditi A, Mariotti C, Bjorkhem I, Di Donato S, Cattaneo E. Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis. 2007;28:133\u201342.","journal-title":"Neurobiol Dis"},{"key":"5053_CR27","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","volume":"16","author":"M Valenza","year":"2007","unstructured":"Valenza M, Carroll JB, Leoni V, Bertram LN, Bjorkhem I, Singaraja RR, Di Donato S, Lutjohann D, Hayden MR, Cattaneo E. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum Mol Genet. 2007;16:2187\u201398.","journal-title":"Hum Mol Genet"},{"key":"5053_CR28","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, MacDonald M, Wellington C, DiDonato S, Hayden M, Cattaneo E. Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci. 2010;30:10844\u201350.","journal-title":"J Neurosci"},{"key":"5053_CR29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","volume":"7","author":"M Valenza","year":"2015","unstructured":"Valenza M, Chen JY, Di Paolo E, Ruozi B, Belletti D, Ferrari Bardile C, Leoni V, Caccia C, Brilli E, Di Donato S, Boido MM, Vercelli A, Vandelli MA, Forni F, Cepeda C, Levine MS, Tosi G, Cattaneo E. Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice. EMBO Mol Med. 2015;7:1547\u201364.","journal-title":"EMBO Mol Med"},{"key":"5053_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jmg.36.10.739","volume":"36","author":"Y Narain","year":"1999","unstructured":"Narain Y, Wyttenbach A, Rankin J, Furlong RA, Rubinsztein DC. A molecular investigation of true dominance in Huntington\u2019s disease. J Med Genet. 1999;36:739\u201346.","journal-title":"J Med Genet"},{"key":"5053_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/auto.4451","volume":"3","author":"S Kimura","year":"2007","unstructured":"Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3:452\u201360.","journal-title":"Autophagy"},{"key":"5053_CR32","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1093\/brain\/awv298","volume":"138","author":"C Nobrega","year":"2015","unstructured":"Nobrega C, Carmo-Silva S, Albuquerque D, Vasconcelos-Ferreira A, Vijayakumar UG, Mendonca L, Hirai H, de Almeida LP. Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease. Brain J Neurol. 2015;138:3537\u201354.","journal-title":"Brain J Neurol"},{"key":"5053_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/hmg\/ddy328","volume":"28","author":"A Marcelo","year":"2019","unstructured":"Marcelo A, Brito F, Carmo-Silva S, Matos CA, Alves-Cruzeiro J, Vasconcelos-Ferreira A, Koppenol R, Mendonca L, de Almeida LP, Nobrega C. Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease models. Hum Mol Genet. 2019;28:51\u201363.","journal-title":"Hum Mol Genet"},{"key":"5053_CR34","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, Sabatini DM. Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.","journal-title":"Genome Biol"},{"key":"5053_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12311-012-0432-0","volume":"12","author":"C Nobrega","year":"2013","unstructured":"Nobrega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Conceicao M, Deglon N, de Almeida LP. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology. Cerebellum (London, England). 2013;12:441\u201355.","journal-title":"Cerebellum (London, England)"},{"key":"5053_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00401-019-02019-7","volume":"138","author":"C Nobrega","year":"2019","unstructured":"Nobrega C, Mendonca L, Marcelo A, Lamaziere A, Tome S, Despres G, Matos CA, Mechmet F, Langui D, den Dunnen W, de Almeida LP, Cartier N, Alves S. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Acta Neuropathol. 2019;138:837\u201358.","journal-title":"Acta Neuropathol"},{"key":"5053_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/mt.2009.175","volume":"18","author":"E Hudry","year":"2010","unstructured":"Hudry E, Van Dam D, Kulik W, De Deyn PP, Stet FS, Ahouansou O, Benraiss A, Delacourte A, Bougneres P, Aubourg P, Cartier N. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer\u2019s disease. Mol Ther. 2010;18:44\u201353.","journal-title":"Mol Ther"},{"key":"5053_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","volume":"260","author":"I Bjorkhem","year":"2006","unstructured":"Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006;260:493\u2013508.","journal-title":"J Intern Med"},{"key":"5053_CR39","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","volume":"78","author":"DW Russell","year":"2009","unstructured":"Russell DW, Halford RW, Ramirez DM, Shah R, Kotti T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem. 2009;78:1017\u201340.","journal-title":"Annu Rev Biochem"},{"key":"5053_CR40","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/cne.21605","volume":"507","author":"DM Ramirez","year":"2008","unstructured":"Ramirez DM, Andersson S, Russell DW. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol. 2008;507:1676\u201393.","journal-title":"J Comp Neurol"},{"key":"5053_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3858\/emm.2012.44.2.031","volume":"44","author":"JH Son","year":"2012","unstructured":"Son JH, Shim JH, Kim K-H, Ha J-Y, Han JY. Neuronal autophagy and neurodegenerative diseases. Exp Mol Med. 2012;44:89.","journal-title":"Exp Mol Med"},{"key":"5053_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","volume":"38","author":"DD Martin","year":"2015","unstructured":"Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 2015;38:26\u201335.","journal-title":"Trends Neurosci"},{"key":"5053_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/neup.12433","volume":"38","author":"A Sittler","year":"2018","unstructured":"Sittler A, Muriel MP, Marinello M, Brice A, den Dunnen W, Alves S. Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients. Neuropathology. 2018;38:113\u201324.","journal-title":"Neuropathology"},{"key":"5053_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-014-1289-8","volume":"128","author":"S Alves","year":"2014","unstructured":"Alves S, Cormier-Dequaire F, Marinello M, Marais T, Muriel MP, Beaumatin F, Charbonnier-Beaupel F, Tahiri K, Seilhean D, El Hachimi K, Ruberg M, Stevanin G, Barkats M, den Dunnen W, Priault M, Brice A, Durr A, Corvol JC, Sittler A. The autophagy\/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice. Acta Neuropathol. 2014;128:705\u201322.","journal-title":"Acta Neuropathol"},{"key":"5053_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/hmg\/ddm294","volume":"17","author":"S Sarkar","year":"2008","unstructured":"Sarkar S, Krishna G, Imarisio S, Saiki S, O\u2019Kane CJ, Rubinsztein DC. A rational mechanism for combination treatment of Huntington\u2019s disease using lithium and rapamycin. Hum Mol Genet. 2008;17:170\u20138.","journal-title":"Hum Mol Genet"},{"key":"5053_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12017-018-8482-1","volume":"20","author":"K Pierzynowska","year":"2018","unstructured":"Pierzynowska K, Gaffke L, Ha\u0107 A, Mantej J, Niedzia\u0142ek N, Brokowska J, W\u0119grzyn G. Correction of Huntington\u2019s disease phenotype by genistein-induced autophagy in the cellular model. Neuromol Med. 2018;20:112\u201323.","journal-title":"Neuromol Med"},{"key":"5053_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O\u2019Kane CJ, Floto RA, Rubinsztein DC. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4:295\u2013305.","journal-title":"Nat Chem Biol"},{"key":"5053_CR48","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1093\/brain\/awt144","volume":"136","author":"I Nascimento-Ferreira","year":"2013","unstructured":"Nascimento-Ferreira I, N\u00f3brega C, Vasconcelos-Ferreira A, Onofre I, Albuquerque D, Aveleira C, Hirai H, D\u00e9glon N, Pereira de Almeida L. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. Brain. 2013;136:2173\u201388.","journal-title":"Brain"},{"key":"5053_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jnc.14541","volume":"148","author":"CA Matos","year":"2019","unstructured":"Matos CA, Pereira de Almeida L, N\u00f3brega C. Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy. J Neurochem. 2019;148:8\u201328.","journal-title":"J Neurochem"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05053-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T23:30:05Z","timestamp":1618011005000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05053-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5053"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05053-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"29 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manuscript does not contain any individual person\u2019s data in any form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}